|

Androgen Receptor Signaling Inhibitor Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ARSI

Pipeline

Phase 2: 1

Top Sponsors

  • University of Miami1

Indications

  • Hormone Sensitive Prostate Cancer1
  • Prostate Adenocarcinoma1
  • Prostate Cancer1
  • Cancer1

Miami, Florida1 trial

PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer

University of Miami

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.